Literature DB >> 22518009

Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh.

Sweta M Patel1, Mohammad Arif Rahman, M Mohasin, M Asrafuzzaman Riyadh, Daniel T Leung, Mohammad Murshid Alam, Fahima Chowdhury, Ashraful I Khan, Ana A Weil, Amena Aktar, Mohammad Nazim, Regina C LaRocque, Edward T Ryan, Stephen B Calderwood, Firdausi Qadri, Jason B Harris.   

Abstract

Vibrio cholerae O1 causes cholera, a dehydrating diarrheal disease. We have previously shown that V. cholerae-specific memory B cell responses develop after cholera infection, and we hypothesize that these mediate long-term protective immunity against cholera. We prospectively followed household contacts of cholera patients to determine whether the presence of circulating V. cholerae O1 antigen-specific memory B cells on enrollment was associated with protection against V. cholerae infection over a 30-day period. Two hundred thirty-six household contacts of 122 index patients with cholera were enrolled. The presence of lipopolysaccharide (LPS)-specific IgG memory B cells in peripheral blood on study entry was associated with a 68% decrease in the risk of infection in household contacts (P = 0.032). No protection was associated with cholera toxin B subunit (CtxB)-specific memory B cells or IgA memory B cells specific to LPS. These results suggest that LPS-specific IgG memory B cells may be important in protection against infection with V. cholerae O1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22518009      PMCID: PMC3370438          DOI: 10.1128/CVI.00037-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  30 in total

1.  Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh.

Authors:  E T Ryan; U Dhar; W A Khan; M A Salam; A S Faruque; G J Fuchs; S B Calderwood; M L Bennish
Journal:  Am J Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.345

2.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

Authors:  Shane Crotty; Rachael D Aubert; John Glidewell; Rafi Ahmed
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

3.  Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens.

Authors:  Dominic F Kelly; Andrew J Pollard; E Richard Moxon
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

4.  Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.

Authors:  F Qadri; F Ahmed; M M Karim; C Wenneras; Y A Begum; M Abdus Salam; M J Albert; J R McGhee
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Stimulation of intestinal adenyl cyclase by cholera toxin.

Authors:  G W Sharp; S Hynie
Journal:  Nature       Date:  1971-01-22       Impact factor: 49.962

6.  The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement.

Authors:  S H Neoh; D Rowley
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

7.  Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site.

Authors:  D Cassel; Z Selinger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

8.  Studies of cholera El Tor in the Philippines. 3. Transmission of infection among household contacts of cholera patients.

Authors:  J F Tamayo; W H Mosley; M G Alvero; P R Joseph; C Z Gomez; T Montague; J J Dizon; D A Henderson
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

9.  Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.

Authors:  Debasish Saha; Regina C LaRocque; Ashraful I Khan; Jason B Harris; Yasmin Ara Begum; Syed M Akramuzzaman; Abu S G Faruque; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  J Infect Dis       Date:  2004-05-25       Impact factor: 5.226

10.  The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients.

Authors:  W H Mosley; S Ahmad; A S Benenson; A Ahmed
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

View more
  47 in total

1.  Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.

Authors:  Kara J Levinson; Magdia De Jesus; Nicholas J Mantis
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

2.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

3.  Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.

Authors:  Douglas J Haney; Michael D Lock; Marc Gurwith; Jakub K Simon; Glenn Ishioka; Mitchell B Cohen; Beth D Kirkpatrick; Caroline E Lyon; Wilbur H Chen; Marcelo B Sztein; Myron M Levine; Jason B Harris
Journal:  Vaccine       Date:  2018-04-11       Impact factor: 3.641

4.  Mucosal and Cellular Immune Responses to Norwalk Virus.

Authors:  Sasirekha Ramani; Frederick H Neill; Antone R Opekun; Mark A Gilger; David Y Graham; Mary K Estes; Robert L Atmar
Journal:  J Infect Dis       Date:  2015-01-29       Impact factor: 5.226

5.  Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Authors:  Marcela F Pasetti; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

6.  Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.

Authors:  Taher Uddin; Amena Aktar; Peng Xu; Russell A Johnson; M Arifur Rahman; Daniel T Leung; Sadia Afrin; Aklima Akter; Mohammad Murshid Alam; Atiqur Rahman; Fahima Chowdhury; Ashraful I Khan; Taufiqur Rahman Bhuiyan; Meagan K Bufano; Rasheduzzaman Rashu; Yanan Yu; Ying Wu-Freeman; Jason B Harris; Regina C LaRocque; Richelle C Charles; Pavol Kováč; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  Am J Trop Med Hyg       Date:  2014-03-31       Impact factor: 2.345

Review 7.  Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.

Authors:  Sachin N Desai; Alejandro Cravioto; Dipika Sur; Suman Kanungo
Journal:  Hum Vaccin Immunother       Date:  2014-05-26       Impact factor: 3.452

8.  The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.

Authors:  Leslie M Mayo-Smith; Jakub K Simon; Wilbur H Chen; Douglas Haney; Michael Lock; Caroline E Lyon; Stephen B Calderwood; Beth D Kirkpatrick; Mitchell Cohen; Myron M Levine; Marc Gurwith; Jason B Harris
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

9.  Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh.

Authors:  Ana A Weil; Yasmin Begum; Fahima Chowdhury; Ashraful I Khan; Daniel T Leung; Regina C LaRocque; Richelle C Charles; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Am J Trop Med Hyg       Date:  2014-08-11       Impact factor: 2.345

10.  Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.

Authors:  Russell A Johnson; Taher Uddin; Amena Aktar; M Mohasin; Mohammad Murshid Alam; Fahima Chowdhury; Jason B Harris; Regina C LaRocque; Meagan Kelly Bufano; Yanan Yu; Ying Wu-Freeman; Daniel T Leung; David Sarracino; Bryan Krastins; Richelle C Charles; Peng Xu; Pavol Kovác; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.